Prospective Study
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Mar 24, 2024; 15(3): 419-433
Published online Mar 24, 2024. doi: 10.5306/wjco.v15.i3.419
Nomogram based on multimodal magnetic resonance combined with B7-H3mRNA for preoperative lymph node prediction in esophagus cancer
Yan-Han Xu, Peng Lu, Ming-Cheng Gao, Rui Wang, Yang-Yang Li, Rong-Qi Guo, Wei-Song Zhang, Jian-Xiang Song
Yan-Han Xu, Ming-Cheng Gao, Rui Wang, Yang-Yang Li, Rong-Qi Guo, Wei-Song Zhang, School of Clinical Sciences, Graduate School of Nantong University, Yancheng 226019, Jiangsu Province, China
Yan-Han Xu, Ming-Cheng Gao, Rui Wang, Yang-Yang Li, Rong-Qi Guo, Wei-Song Zhang, Jian-Xiang Song, Department of Thoracic Surgery, Yancheng Third People's Hospital, The Affiliated Hospital 6 of Nantong University, Yancheng 224000, Jiangsu Province, China
Peng Lu, Department of Imaging, Yancheng Third People's Hospital, The Affiliated Hospital 6 of Nantong University, Yancheng 224000, Jiangsu Province, China
Author contributions: Xu YH performed the majority of the writing, prepared the figures and tables; Xu YH, Lu P and Gao MC performed data accusation and writing; Wang R, Li YY, Guo RQ, and Zhang WS helped proofread the abbreviations and terminology in the manuscript; Song JX provided the input in writing the paper; Xu YH and Lu P designed the outline and coordinated the writing of the paper.
Supported by The Yancheng Key Research and Development Program (Social Development), No. YCBE202324.
Institutional review board statement: The study was reviewed and approved by the Ethics Committee of Yancheng Third People's Hospital Institutional Review Board, Approval No. 2022-10.
Informed consent statement: Considering that the relevant examinations in this study do not pose significant physical or harm to the patients' interests, the requirement for obtaining informed consent from the patients has been waived by the committee.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: Technical appendix, statistical code, and dataset available from the corresponding author at jxsongycsy@163.com.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Jian-Xiang Song, MD, PhD, Chief Doctor, Chief Physician, Dean, Doctor, Surgeon, Department of Thoracic Surgery, Yancheng Third People's Hospital, The Affiliated Hospital 6 of Nantong University, No. 2 Xindu West Road, Yandu Street, Yandu District, Yancheng 224000, Jiangsu Province, China. jxsongycsy@163.com
Received: November 19, 2023
Peer-review started: November 19, 2023
First decision: January 9, 2024
Revised: January 15, 2024
Accepted: February 6, 2024
Article in press: February 6, 2024
Published online: March 24, 2024
Processing time: 124 Days and 0 Hours
Core Tip

Core Tip: Accurate tumor-node-metastasis staging plays a critical role in devising treatment strategies for esophageal cancer (EC), particularly in assessing lymph node (LN) metastasis. Nevertheless, existing techniques for diagnosing LN in EC are currently constrained by limited accuracy. In light of this, our study endeavors to construct a clinical column chart that can enhance the assessment of LN status, furnishing a valuable point of reference for the diagnosis and treatment of EC.